絞り込み

16641

広告

観測船しらせのヘリから機器投下 (デイリースポーツ)

【南大洋共同】南極・昭和基地へ向かっている観測船「しらせ」に乗る第61次南極観測隊は11日(日本時間同)、気候変動により融解が懸念されている「トッテン氷河」の沖...

  1. 東京パラ ドキュメンタリー共同制作へ I...
  2. 「スター・ウォーズ」完結編 監督や出演者...
  3. 大飯原発1・2号機の廃炉計画を認可 10...
  4. めおと漫才 宮川花子さん 多発性骨髄腫を...

ニュース一覧

1379件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation.

[Direct oral anticoagulants in the treatment of cancer-associated thrombosis].

Newer Oral Anticoagulant in Chronic Kidney Disease: What we Should Know.

A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.

Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease.

Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort.

[A Case Report of Endovascular Thrombectomy for Internal Carotid Artery Thromboembolism after Left Upper Lobectomy of Lung Cancer].

Pharmacogenomics of anticoagulation therapy: the last 10 years.

Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.

Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology.

Clinical implications of incidental venous thromboembolism in cancer patients.

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial.

Activated Clotting Time on the Day of Atrial Fibrillation Ablation for Minimally Interrupted and Uninterrupted Direct Oral Anticoagulation Therapy: Sequential Changes, Differences among Direct Oral Anticoagulants, and Ablation Safety Outcomes.

Efficacy and Safety of Edoxaban Compared to Warfarin According to the Burden of Diseases in Patients with Atrial Fibrillation: Insights from the ENGAGE AF-TIMI 48.

Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis.

Residual anticoagulation activity in atrial fibrillation patients with temporary interrupted direct oral anticoagulants: Comparisons across 4 drugs.

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention.

Oral anticoagulation in emergency department patients: high rates of off-label doses,no difference in bleeding rates.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります